Stock AVRO AVROBIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News AVROBIO, Inc.

Equities

AVRO

US05455M1009

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
1.21 USD +2.11% Intraday chart for AVROBIO, Inc. +0.83% -11.03%
03-21 North American Morning Briefing : Investors -2- DJ
03-14 AVROBIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tectonic Therapeutic Initiates Phase 1B Study for TX45 in Group 2 Pulmonary Hypertension in Patients with Preserved Ejection Fraction Heart Failure
AQ
North American Morning Briefing : Investors -2-
DJ
AVROBIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
AVROBIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AVROBIO, Inc. - AVRO
BU
Shareholder Alert: Ademi LLP investigates whether AVROBIO, Inc. has obtained a Fair Price in its transaction with Tectonic
PR
AVRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AVROBIO, Inc. Is Fair to Shareholders
BU
Transcript : AVROBIO, Inc., Tectonic Therapeutic, Inc. - M&A Call
AVROBIO and Tectonic Therapeutic Announce Merger
BU
AVROBIO, Inc. entered into an agreement to acquire Tectonic Therapeutic, Inc.
CI
North American Morning Briefing : S&P 500 Eyes -2-
DJ
Mizuho Securities Cuts Avrobio Price Target to $2 From $5, Buy Rating Kept
MT
North American Morning Briefing : Caution Dominates Ahead of CPI Print
DJ
AVROBIO, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
North American Morning Briefing : China Angst -2-
DJ
AVROBIO, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Wells Fargo Adjusts Price Target on AVROBIO to $2 From $2.50, Maintains Overweight Rating
MT
North American Morning Briefing : Optimism Set to -2-
DJ
Sector Update: Health Care Stocks Slipping Late Wednesday
MT
Sector Update: Health Care Stocks Softer in Afternoon Trading
MT
Wedbush Downgrades AVROBIO to Neutral From Outperform on Halted Development of Gene Therapy Programs, Exploring Alternatives; PT is $2
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVRO Stock
  4. News AVROBIO, Inc.